Poolbeg Pharma shares rise after receiving South Korean patent approval for cancer drug

Poolbeg Pharma reports £4.8m cash as it launches cancer-drug trial

Poolbeg Pharma reports positive FDA feedback on treatment

Poolbeg Pharma gets Canadian patent approval for cancer drug

Poolbeg Pharma eyes partnerships as key trial data nears

Poolbeg expects several clinical trial results in 2026

Cathal Friel-founded Poolbeg Pharma secures key European patent

Cathal Friel’s Poolbeg Pharma partners with J&J for cancer treatment trial

Poolbeg Pharma ‘well-positioned to deliver’ for shareholders as it announces £10m cash balance

Poolbeg Pharma announces ‘milestone’ cancer therapy clinical trial agreement

Poolbeg Pharma
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.